UroGen Pharma CMO Mark Schoenberg Sells 6,673 Shares at $19.69/Share.

UroGen Pharma Ltd. recently announced that Chief Medical Officer Schoenberg Mark has executed a series of transactions involving the sale of shares. Specifically, he sold 1,843 shares at a price of $19.69 per share on February 3, 2026, as well as 3,686 shares at the same price on the same date. Additionally, he sold 1,844 shares at $19.69 per share on February 3, 2026.